U.S. approves HIV-prevention drug

U.S. approves HIV-prevention drug

PanARMENIAN.Net - The U.S. has approved the first drug shown to reduce the risk of HIV infection, a milestone in the 30-year battle against the virus that causes Aids, Belfast Telegraph said.

The Food and Drug Administration approved Gilead Sciences' pill Truvada as a preventive measure for people who are at high risk of acquiring HIV, such as those who have sex with HIV-infected partners.

Gilead Sciences has marketed Truvada since 2004 as a treatment for people who are infected with the virus, but company studies have shown the drug can prevent people from contracting HIV when used as a precautionary measure.

A three-year study found that daily doses cut the risk of infection in healthy gay and bisexual men by 42%, when accompanied by condoms and counselling.

 Top stories
On July 10, Armenian forces curbed a sabotage attempt as Azeris tried to infiltrate the border in the NKR’s Karvachar area.
The protesters were demanding to be played their wages for 18 months, also expressing concern over the plant’s future.
Kind and eternally young at heart – she was always 20, though in 2 days, on July 10 she’d have celebrated her 57th birthday.
“We applaud this first attempt to bring a wide range of human rights issues under one umbrella,” the organizations said.
Partner news